Seifert, Matthias
Benmebarek, Mohamed-Reda
Briukhovetska, Daria
Märkl, Florian
Dörr, Janina
Cadilha, Bruno L.
Jobst, Jakob
Stock, Sophia http://orcid.org/0000-0002-5072-5013
Andreu-Sanz, David
Lorenzini, Theo
Grünmeier, Ruth http://orcid.org/0000-0002-9044-3600
Oner, Arman
Obeck, Hannah
Majed, Lina
Dhoqina, Dario
Feinendegen, Manouk
Gottschlich, Adrian http://orcid.org/0000-0002-2898-4182
Zhang, Jin
Schindler, Ulrike
Endres, Stefan http://orcid.org/0000-0002-4703-537X
Kobold, Sebastian http://orcid.org/0000-0002-5612-4673
Article History
Received: 7 January 2022
Revised: 13 September 2022
Accepted: 4 October 2022
First Online: 20 October 2022
Competing interests
: Parts of this work have been performed for the doctoral thesis of MS at the Ludwig-Maximilians-Universität München. SE and SK are inventors of several patent applications filed by the Ludwig-Maximilians-Universität München in the field of immunooncology. SE and SK received research support from TCR2 Inc and Tabby Therapeutics for work unrelated to the present manuscript. SK received research support from Arcus Biosciences to perform parts of the present study. US is a former employee of Arcus Biosciences and holds stocks from Arcus Biosciences and Amgen. The authors declare no other competing interests.
: Collection of peripheral blood samples from healthy donors were approved by the institutional review board of the Ludwig-Maximilians-Universität (Munich, Germany). The study was performed in accordance with the Declaration of Helsinki.